Tucatinib in Combination w/Doxil for HER2+ metastatic breast ca

Phase 2 Single Arm Trial with a Safety Lead-in of Tucatinib in Combination with Doxil for the Treatment of HER2+ Metastatic Breast Cancer (BRE 381)

Disease Types: Breast

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

Phase 2 Single Arm Trial with a Safety Lead-in of Tucatinib in Combination with Doxil for the Treatment of HER2+ Metastatic Breast Cancer (BRE 381)

For More Information:

https://clinicaltrials.gov/search?term=Phase%202%20Single%20Arm%20Trial%20with%20a%20Safety%20Lead-in%20of%20Tucatinib%20in%20Combination%20with%20Doxil%20for%20the%20Treatment%20of%20HER2%2B%20Metastatic%20Breast%20Cancer%20(BRE%20381)